Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Becton launches ultrafine pen needles in US:

This article was originally published in Clinica

Executive Summary

Becton Dickinson is launching a range of pen needles for the diabetic market, which the company claims are the thinnest on sale in the US. The company recently won a legal case which prevented rival pen injector manufacturer Novo Nordisk claiming that its needle worked better in Novo's own pen than in Becton Dickinson's (see Clinica No 801, p13). Short pen needles are used for children and those new to insulin injection.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts